Aqua Pharma

in press and stories

SEATRU™ KICKS OFF WITH 2-YEAR RESEARCH PROGRAM

June 2022

Aqua Pharma are joining forces with microbial fingerprinting experts KYTOS to develop SEATRU™ – a unique new service platform offering shrimp farmers worldwide effective microbial control through precise dosing recommendations.

The initiative kicks off in July 2022 with a two-year research project based in Indonesia with local partner eFishery, the world’s largest aquaculture tech start-up.

Aqua pharma expands: opens new office in chile and new subsidiary for salmon farming

May 2022

Chile: The Norwegian supplier of hydrogen peroxide will be based in Puerto Montt for aquaculture and from this year, they will also offer food safety services to the national industry.

The Norwegian provider of disease prevention and control systems for salmon farming, Aqua Pharma, is completing a major expansion in Chile. Recently, it opened new offices in Puerto Montt, where the Nordic company and its aquaculture subsidiary, Aquatiq, will meet.

M/S Steyer with Significant upgrade – opens up new opportunities for delousing

May 2022

M/S Steyer has undergone a month-long upgrade which now makes it possible to delouse and bring the fish back into the same salmon farm from which it is retrieved.

For the past month, M/S Steyer har been in Langevåg at Cflow Fish Handling AS to install a new gutter to carry fish back into the same salmon pen as they are taken from. The Hydrolicer system has also been upgraded with state-of-the-art control features and cameras.

BREEZE concept wins EUROPEAN SUSTAINABLE AQUACULTURE COMPETITION

June 2021

The BREEZE initiative which is being developed by a consortium made up of Aqua Pharma GroupPulcea and the Norwegian University of Science & Technology,
was one of the four projects chosen by EIT Food for inclusion in its 2021 Business Plan for Sustainable Aquaculture.

BREEZE combines Aqua Pharma’s existing hydrogen peroxide treatment with the acoustic based technology pioneered by Pulcea to improve the efficiency of sea lice removal from fish in a gentle treatment. A post-treatment neutralisation leads to decomposition of the hydrogen peroxide into oxygen and water, making the system suitable for use even in environmentally sensitive areas.

Read more about the BREEZE consortium project on our INNOVATION page, or follow us on Social Media to stay tuned.

STRONGER TOGETHER,
A NEW GOVERNANCE STRUCTURE
AQUA PHARMA GROUP

September 2019

Paramove producer, Solvay and Norwegian Food Hygiene expert, Aquatiq have concluded a joint-venture agreement regarding Aqua Pharma Group, reinforcing their long-term collaboration to serve aquaculture customers. With this strong shareholder alliance, Aqua Pharma will be able to put an even stronger focus on research & development, new treatment development, for a diverse range of aquaculture segments.

Aqua Pharma INVESTS in START-UP TECHNOLOGY COMPANY Pulcea

May 2020

The development of an innovative new treatment method to control lice in farmed salmon has moved a step closer with the merging of interests between two experts in the field. Pulcea, which has been developing the use of sound energy to improve the efficiency of existing sea lice treatments, has received investments from Aqua Pharma to accelerate the delivery of its technology, from testing through to commercialisation.

Contact us

We’re happy to answer any questions and get you introduced to Aqua Pharma.

Send us an e-mail, call one of our regional managers or fill out the form. Either way we will respond as quickly as possible

post@aqua-pharma.com